List view / Grid view

Oxford University

Filter the results

 

article

Boom times for pharma M&A

18 February 2021 | By

Global mergers and acquisitions (M&A) activity last year was expected to decline from 2019 levels, mainly due to the COVID-19 pandemic and resulting uncertainty around the global economy, trade tensions between the US and China, and the presidential election in the US. However, James Baillieu from Bird & Bird reveals…

content_hub

Infectious Diseases Data Observatory

29 March 2018 | By

Poor quality medicines threaten us all, but have the greatest impact on vulnerable populations in countries with inadequate medicine laws and regulation. Keeping patients safe and ensuring that the benefits of modern medicine are delivered to those in need are the key goals of a wide range of organisations which…